Literature DB >> 3584838

Metabolic fate and elimination in milk, urine and bile of deoxynivalenol following administration to lactating sheep.

D B Prelusky, D M Veira, H L Trenholm, B C Foster.   

Abstract

Using a combination of radioisotopic counting and chromatographic detection techniques, the kinetics and metabolic fate of deoxynivalenol (DON) in plasma, urine and bile were studied in lactating sheep, as was the transmission of residues to milk. Following intravenous administration, the plasma clearance of 14C-DON-derived radioactivity was rapid and followed a tri-phasic decay curve comprised of a bi-exponential decrease in DON (rapid distribution phase, t1/2 alpha = 16.2 min; slower elimination phase t1/2 beta = 66.5 min) and the formation and elimination (t1/2 beta = 188.0 min) of its major plasma metabolite, DON-glucuronide conjugate, which accounted for 13% of the plasma radioactivity levels. DON was rapidly cleared from the body by metabolism to 7 possible metabolites, which were excreted essentially in the urine (91%) and to a lesser extent in the bile (6%). Most (67%) of the recovered radioactivity was in the form of the glucuronide conjugates of DON (54%) and the de-epoxide metabolite, DOM-1 (13%). Excretion of unmetabolized DON accounted for 11%. The remaining recovered dose (18%) comprised of minor amounts of DOM-1 (6%), DON-sulfate conjugate (2%) and 3 unidentified radioactive components (10%). Studies on the presence of DON-derived residues in milk indicated that, relative to the dose, only trace amounts were transmitted following either oral or iv administration of the toxin.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3584838     DOI: 10.1080/03601238709372550

Source DB:  PubMed          Journal:  J Environ Sci Health B        ISSN: 0360-1234            Impact factor:   1.990


  8 in total

1.  Subfertility and growth restriction in a new galactose-1 phosphate uridylyltransferase (GALT) - deficient mouse model.

Authors:  Manshu Tang; Anwer Siddiqi; Benjamin Witt; Tatiana Yuzyuk; Britt Johnson; Nisa Fraser; Wyman Chen; Rafael Rascon; Xue Yin; Harish Goli; Olaf A Bodamer; Kent Lai
Journal:  Eur J Hum Genet       Date:  2014-02-19       Impact factor: 4.246

2.  Analysis of Fusarium graminearum mycotoxins in different biological matrices by LC/MS.

Authors:  A C Bily; L M Reid; M E Savard; R Reddy; B A Blackwell; C M Campbell; A Krantis; T Durst; B J R Philogène; J T Arnason; C Regnault-Roger
Journal:  Mycopathologia       Date:  2004-01       Impact factor: 2.574

3.  Tissue distribution and proinflammatory cytokine gene expression following acute oral exposure to deoxynivalenol: comparison of weanling and adult mice.

Authors:  James J Pestka; Chidozie J Amuzie
Journal:  Food Chem Toxicol       Date:  2008-07-09       Impact factor: 6.023

4.  Fusarium mycotoxins in total mixed rations for dairy cows.

Authors:  María Rodríguez-Blanco; Sonia Marín; Vicente Sanchis; Antonio J Ramos
Journal:  Mycotoxin Res       Date:  2020-02-12       Impact factor: 3.833

5.  The fate and tissue disposition of deoxynivalenol in broiler chickens.

Authors:  Sasithorn Pralatnet; Saranya Poapolathep; Kanjana Imsilp; Phanwimol Tanhan; Supaporn Isariyodom; Susumu Kumagai; Amnart Poapolathep
Journal:  J Vet Med Sci       Date:  2015-04-04       Impact factor: 1.267

6.  Sulfation of deoxynivalenol, its acetylated derivatives, and T2-toxin.

Authors:  Philipp Fruhmann; Philipp Skrinjar; Julia Weber; Hannes Mikula; Benedikt Warth; Michael Sulyok; Rudolf Krska; Gerhard Adam; Erwin Rosenberg; Christian Hametner; Johannes Fröhlich
Journal:  Tetrahedron       Date:  2014-08-26       Impact factor: 2.457

7.  Deoxynivalenol-sulfates: identification and quantification of novel conjugated (masked) mycotoxins in wheat.

Authors:  Benedikt Warth; Philipp Fruhmann; Gerlinde Wiesenberger; Bernhard Kluger; Bojan Sarkanj; Marc Lemmens; Christian Hametner; Johannes Fröhlich; Gerhard Adam; Rudolf Krska; Rainer Schuhmacher
Journal:  Anal Bioanal Chem       Date:  2014-12-10       Impact factor: 4.142

8.  Identification of a novel human deoxynivalenol metabolite enhancing proliferation of intestinal and urinary bladder cells.

Authors:  Benedikt Warth; Giorgia Del Favero; Gerlinde Wiesenberger; Hannes Puntscher; Lydia Woelflingseder; Philipp Fruhmann; Bojan Sarkanj; Rudolf Krska; Rainer Schuhmacher; Gerhard Adam; Doris Marko
Journal:  Sci Rep       Date:  2016-09-23       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.